RETRACTION: UBE2C Induces Cisplatin Resistance via ZEB1/2‐Dependent Upregulation of ABCG2 and ERCC1 in NSCLC Cells

Journal of Oncology · 2025

Read RETRACTION: UBE2C Induces Cisplatin Resistance via ZEB1/2‐Dependent Upregulation of ABCG2 and ERCC1 in NSCLC Cells by Journal of Oncology (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12767061.txt.

Description

A peer-reviewed research article from Europe PMC (2025). nd its correction (https://onlinelibrary.wiley.com/doi/10.1155/2020/5025641), has been retracted by John Wiley & Sons Ltd. The retraction has been agreed due to multiple concerns with the figures, some of which have been raised on PubPeer [1].

Catalog record

CREATORJournal of Oncology
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE6 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12767061

Browse the full library · About the Tower of Babel